Yuval Horn to participate in an Executive Briefing about: Risks and Rewards of Expanding into the United States, on January 31, 2016
January 12, 2016
Yuval Horn and Orly Sternfeld of Horn & Co. advised Zebra Medical Vision Ltd. in its collaboration agreement with Dell Services to enable next-generation clinical insights and better population health management
November 25, 2015
Yuval Horn, Keren Kanir and Uri Dotan of Horn & Co. represented Vascular Biogenics Ltd. in its $15 Million follow-on offering on NASDAQ
November 3, 2015
Yuval Horn was announced as the incoming Co-Chair of the International Bar Association Technology Law Committee
October 19, 2015
Yuval Horn to moderate a panel relating to Regulation of Genetic Testing at the IBA Annual Conference in Vienna in October, 2015
September 2, 2015
Horn & Co. represented cCam Biotherapeutics Ltd. and its shareholders in the acquisition by Merck Sharp & Dohme for $605 million.
July 28, 2015
Taboola.com increases its $117 million private financing round, and closes follow-on investments with Baidu Inc. and DailyMail.com.
June 21, 2015
Horn & Co. listed by iam Magazine (Intellectual Asset Management) as one of the top 6 recommended Israeli firms in the field of Licensing.
June 18, 2015
Adv. Yuval Horn participated in the 3rd Annual IBA World Life Sciences Conference
June 1, 2015
Biolight Israeli Life Sciences Investments Ltd (TASE: BOLT) executes memorandum for strategic cooperation in China and closes $6.2 million investment with investors based in Hong Kong.
May 12, 2015
